Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy-Reference-Cited by-同舟云学术

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

Published:2014-10-31 Issue:12 Volume:6 Page:1561-1576
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Ebos John ML¹,Mastri Michalis¹,Lee Christina R²,Tracz Amanda¹,Hudson John M²,Attwood Kristopher³,Cruz‐Munoz William R²,Jedeszko Christopher²,Burns Peter²⁴,Kerbel Robert S²⁴

Affiliation:

1. Genitourinary Section Department of Medicine Roswell Park Cancer Institute Buffalo NY USA

2. Biological Sciences Platform Sunnybrook Research Institute Toronto ON Canada

3. Department of Biostatistics and Bioinformatics Roswell Park Cancer Institute Buffalo NY USA

4. Department of Medical Biophysics University of Toronto Toronto ON Canada

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201403989

Reference50 articles.

1. Early Primary Tumor Size Reduction Is an Independent Predictor of Improved Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib

2. Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

3. A Phase II Study of Presurgical Sunitinib in Patients With Metastatic Clear-cell Renal Carcinoma and the Primary Tumor In Situ

4. Do targeted agents offer clinical benefit as presurgical therapy?

5. BjarnasonGA NaveenBS KnoxJJ KollmannsbergerM ReaumeN zalewskiP ZMacfarlaneRJ MacKeanMJ HotteSJ YickDet al(2013)A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first‐line therapy for metastatic renal cell cancer. ASCO Annual Meeting #TPS4594

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the efficacy and safety of toceranib phosphate in cats with macroscopic mammary adenocarcinoma;Journal of Feline Medicine and Surgery;2024-08

2. Machine-learning and mechanistic modeling of metastatic breast cancer after neoadjuvant treatment;PLOS Computational Biology;2024-05-03

3. A mathematical model for the role of dopamine-D2 self-regulation in the production of ultradian rhythms;PLOS Computational Biology;2024-05-03

4. A Senescence-Mimicking (Senomimetic) VEGFR TKI Side Effect Primes Tumor Immune Responses via IFN/STING Signaling;Molecular Cancer Therapeutics;2024-04-30

5. Endothelial VEGFR2-PLCγ signaling regulates vascular permeability and antitumor immunity through eNOS/Src;Journal of Clinical Investigation;2023-10-16